| [1] |
Zaki MA,Wada N,Ikeda J,et al．Prognostic implication of types of tumor- associated macrophages in Hodgkin lymphoma[J]． Virchows Arch,2011, 459(4) : 361-6．
|
| [2] |
Mueller CK,Schultze-Mosgau S. Histomorphometric analysis of the phenotypical differentiation of recruited macrophages following subcutaneous implantation of an allogenous acellular dermal matrix[J]. Int J Oral Maxillofac Surg,2011,40(4): 401-7.
|
| [3] |
Noel W, Raes G, Hassanzadeh Ghassabeh G, et al. Alternatively activated macrophages during parasite infections[J]. Trends Parasitol, 2004, 20(3):126-33.
|
| [4] |
Martinez FO, Sica A, Mantovani A, et al. Macrophage activation and polarization [J]. Front Biosci, 2008,13: 453-61.
|
| [5] |
Hao NB, Ku MH, Fan YH, et al. Macrophages in tumor microenviroments and the progression of tumors[J]. Clin Dev Immunol, 2012,2012:948098.
|
| [6] |
Yue ZQ, Liu YP, Ruan JS, et al. Tumor-associated macrophages: a novel potential target for cancer treatment[J]. Chin Med J(Engl), 20 12, 125(18):3305-11.
|
| [7] |
Ben-Baruch A. Inflammation-associated immune suppression in cancer: the roles played by cytokines, chemokines and additional mediators[J]. Semin Cancer Biol, 2006, 16(1):38-52.
|
| [8] |
Mantovani A, Sica A. Macrophages, innate immunity and cancer: balance, tolerance, and diversity[J]. Curr Opin Immunol, 2010, 22 (2):231-7.
|
| [9] |
Flavell RA, Sanjabi S, Wrzesinski SH, et al. The polarization of immune cells in the tumour environment by TGFbeta[J]. Nat Rev Immunol, 2010, 10(8):554-67.
|
| [10] |
Castriconi R, Cantoni C, Della Chiesa M, et al. Transforming growth factor beta 1 inhibits expression of NKp30 and NKG2D receptors: consequences for the NK-mediated killing of dendritic cells[J]. Proc Natl Acad Sci U S A, 2003, 100(7):4120-5.
|
| [11] |
Ito M, Minamiya Y, Kawai H, et al. Tumor-derived TGFbeta-1 induces dendritic cell apoptosis in the sentinel lymph node[J]. J Immunol, 2006, 176(9):5637-43.
|
| [12] |
Weber F, Byrne SN, Le S, et al. Transforming growth factor-beta1 immobilises dendritic cells within skin tumours and facilitates tumour escape from the immune system[J]. Cancer Immunol Immunother, 2005, 54(9):898-906.
|
| [13] |
Maeda H, Shiraishi A. TGF-beta contributes to the shift toward Th2-type responses through direct and IL-10-mediated pathways in tumor-bearing mice[J]. J Immunol, 1996, 156(1):73-8.
|
| [14] |
Thomas DA, Massagué J. TGF-beta directly targets cytotoxic T cell functions during tumor evasion of immune surveillance[J]. Cancer Cell, 2005, 8(5):369-80.
|
| [15] |
Matsuda M,Salazar F, Petersson M, et al. Interleukin 10 pretreatment protects target cells from tumor- and allo- specific cytotoxic T cells and downregulates HLA class I expression[J]. J Exp Med, 1994, 180(6):2371-6.
|
| [16] |
Qin Z, Noffz G, Mohaupt M, et al. Interleukin-10 prevents dendritic cell accumulation and vaccination with granulocytemacrophage colony-stimulating factor gene-modified tumor cells[J]. J Immunol, 1997, 159(2):770-6.
|
| [17] |
Beissert S, Hosoi J, Grabbe S, et al. IL-10 inhibits tumor antigen presentation by epidermal antigen-presenting cells[J]. J Immunol, 19 95, 154(3):1280-6.
|
| [18] |
Sica A, Saccani A, Bottazzi B, et al. Autocrine production of IL-10 mediates defective IL-12 production and NF-kappaB activation in tumor-associated macrophages[J]. J Immunol, 2000, 164(2):762-7.
|
| [19] |
Miotto D, Lo Cascio N, Stendardo M, et al. CD8+ T cells expressing IL-10 are associated with a favourable prognosis in lung cancer[J]. Lung Cancer, 2010, 69(3):355-60.
|
| [20] |
Lopez MV, Adris SK, Bravo AI, et al. IL-12 and IL-10 expression synergize to induce the immune-mediated eradication of established colon and mammary tumors and lung metastasis[J]. J Immunol, 2005, 175(9): 5885-94.
|
| [21] |
Mocellin S, Marincola FM, Young HA. Interleukin-10 and the immune response against cancer: a counterpoint[J]. J Leukocyte Biol, 2005, 78(5):1043-51.
|
| [22] |
Zhang W, Wang L, Zhou D, et al. Expression of tumor-associated macrophages and vascular entothelial growth factor correlates with poor prognosis of peripheral T-cell lymphoma, not otherwise specified[J]. Leuk Lymphoma, 2011, 52(1):46-52．
|
| [23] |
Zeisberger SM,Odermatt B, Marty C,et a1. Clodronate-liposomemediated depletion of tumour-associated macrophages: a new and highly effective antiangiogenic therapy approach[J]. Br J Cancer,2006, 95(3):272-81．
|
| [24] |
Etoh T,Shibuta K,Barnard GF,et a1. Angiogenin expression in human colorectal cancer：the role offocal macrophage infiltration[J].Clin Cancer Res, 2000, 6(9):3545-51．
|
| [25] |
Leek RD,Lewis CE,Whitehouse R,et al. Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma[J].Cancer Res,1996, 56(20) : 4625-9．
|
| [26] |
Sica A,Saccani A,Mantovani A,et a1.Tumor-associated macrophages：a molecular perspective[J].Int Immunopharmacol, 20 02, 2(8):1045-54．
|
| [27] |
Chen JJ,Yao PL,Yuan A,et al. Up-regulation of tumor interleukin-8 expression by infiltrating macrophages: its correlation with tumor angiogenesis and patient survival in non-small cell lung cancer[J]. Clin Cancer Res,2003,9(2): 729-37．
|
| [28] |
Toge H,Inagaki T,Kojimoto Y,et al. Angiogenesis in renal cell carcinoma: the role of tumor-associated macrophages[J] Int J Urol,2009,16(10):801-7．
|
| [29] |
Klimp AH,Hollema H,Kempinga C,et al. Expression of cyclooxygenase-2 and inducible nitric oxide synthase in human ovarian tumors and tumor-associated macrophages[J].Cancer Res,2001,61(19):7305-9.
|
| [30] |
Harmey JH, Dimitriadis E,Kay E,et al. Regulation of macrophage production of vascular endothelial growth factor ( VEGF) by hypoxia and transforming growth factor beta-1[J].Ann Surg Oncol,1998,5(3):271-8.
|
| [31] |
Maruyama K, Li M, Cursiefen C, et al. Inflammation-induced lymphangiogenesis in the cornea arises from CD11b-positive macrophages[J].J Clin Invest,2005,115(9):2363-72.
|
| [32] |
Kerjaschki D.The crucial role of macrophages in lymphangiogenesis [J] J Clin Invest,2005, 115(9);2316-9.
|
| [33] |
Schoppmann SF, Birner P, St?ckl J, et al. Tumor-associated macrophages express lymphatic endothelial growth factors and file related to peritumoral lymphangiogenesis[J].Am J Pathol,2002,161(3):947-56.
|
| [34] |
Oosterling SJ, van der Bij GJ, Meijer GA, et al. Macrophages direct tumour histology and clinical outcome in a colon cancer model[J].J Pathol,2005,207(2):147-55.
|
| [35] |
Chen JJ, Lin YC, Yao PL, et al. Tumor-associated macrophages: the double-edged sword in cancer progression[J].J Clin Oncol,2005,23(5):953-64.
|
| [36] |
Mantovani A, Bottazzi B, Colotta F,et al.The origin and function of tumor-associated macrophages[J].Immunol Today,1992,13(7):265-70.
|
| [37] |
Heusinkveld M,van der Burg SH. Identification and manipulation of tumor associated macrophages in human cancers[J].J Transl Med,2011,9: 216.
|
| [38] |
Nakanishi Y,Nakatsuji M,Seno H,et al. COX-2 inhibition alters the phenotype of tumor-associated macrophages from M2 to M1 in ApcMin/+ mouse polyps[J].Carcinogenesis,2011,32(9):1333-9.
|
| [39] |
Guiducci C,Vicari AP,Sangaletti S,et al.Redirecting in vivo elicited tumor infiltrating macrophages and dendritic cells towards tumor rejection[J].Cancer Res,2005,65(8):3437-46.
|
| [40] |
Ghosh D,Maiti TK. Effects of native and heat-denatured Abrus agglutinin on tumor-associated macrophages in Dalton's lymphoma mice[J].Immunobiology,2007,212(8):667-73.
|
| [41] |
Watkins SK,Egilmez NK,Suttles J,et al.IL-12 rapidly alters the functional profile of tumor-associated and tumor-infiltrating macrophages in vitro and in vivo[J].J Immunol,2007,178(3): 13 57-62.
|
| [42] |
Beatty GL,Chiorean EG,Fishman MP,et al. CD40 agonists alter tumor stroma and show efficacy against pancreatic carcinoma in mice and humans[J].Science,2011,331(6024) :1612-6．
|
下载:
